HK1013315A1 - Novel polypeptide having factor xa inhibitory activity - Google Patents

Novel polypeptide having factor xa inhibitory activity

Info

Publication number
HK1013315A1
HK1013315A1 HK98114597A HK98114597A HK1013315A1 HK 1013315 A1 HK1013315 A1 HK 1013315A1 HK 98114597 A HK98114597 A HK 98114597A HK 98114597 A HK98114597 A HK 98114597A HK 1013315 A1 HK1013315 A1 HK 1013315A1
Authority
HK
Hong Kong
Prior art keywords
polypeptide
factor
novel polypeptide
inhibitory activity
deposited
Prior art date
Application number
HK98114597A
Other languages
English (en)
Inventor
Elisha P Zeelon
Moshe M Werber
Avigdor Levanon
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Publication of HK1013315A1 publication Critical patent/HK1013315A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK98114597A 1993-04-09 1998-12-22 Novel polypeptide having factor xa inhibitory activity HK1013315A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4580593A 1993-04-09 1993-04-09
PCT/US1994/003871 WO1994023735A1 (en) 1993-04-09 1994-04-08 Novel polypeptide having factor xa inhibitory activity

Publications (1)

Publication Number Publication Date
HK1013315A1 true HK1013315A1 (en) 1999-08-20

Family

ID=21939985

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98114597A HK1013315A1 (en) 1993-04-09 1998-12-22 Novel polypeptide having factor xa inhibitory activity

Country Status (15)

Country Link
EP (1) EP0696198B1 (de)
JP (1) JPH08511157A (de)
KR (1) KR960701649A (de)
AT (1) ATE198710T1 (de)
AU (1) AU682361B2 (de)
CA (1) CA2159218A1 (de)
DE (1) DE69426598T2 (de)
DK (1) DK0696198T3 (de)
ES (1) ES2155472T3 (de)
GR (1) GR3035722T3 (de)
HK (1) HK1013315A1 (de)
IL (1) IL109259A0 (de)
NZ (1) NZ265507A (de)
PT (1) PT696198E (de)
WO (1) WO1994023735A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1264575C (zh) 1998-08-06 2006-07-19 山景药品公司 聚乙二醇或聚环氧乙烷－尿酸氧化酶结合物及其应用
MX2007012548A (es) 2005-04-11 2008-03-11 Savient Pharmaceuticals Inc Formas variantes de urato oxidasa y uso de las mismas.
KR20080009111A (ko) 2005-04-11 2008-01-24 새비언트 파마수티컬즈 인크. 유레이트 옥시다아제의 변이형 및 이의 용도
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
ES2532804T3 (es) 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
MX347903B (es) 2009-06-25 2017-05-18 Crealta Pharmaceuticals Llc Metodos y equipos para predecir el riesgo de reaccion a la infusion y perdida de respuesta mediada por anticuerpos al supervisar el acido urico en suero durante una terapia con uricasa conjugada con peg.
US8501241B1 (en) 2012-09-17 2013-08-06 Biopep Solutions, Inc. Treating cancer with a whole, leech saliva extract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
KR960701649A (ko) 1996-03-28
GR3035722T3 (en) 2001-07-31
ATE198710T1 (de) 2001-02-15
EP0696198A1 (de) 1996-02-14
AU6629194A (en) 1994-11-08
NZ265507A (en) 1998-09-24
JPH08511157A (ja) 1996-11-26
CA2159218A1 (en) 1994-10-27
IL109259A0 (en) 1994-07-31
DE69426598T2 (de) 2001-08-09
EP0696198A4 (de) 1999-01-27
DK0696198T3 (da) 2001-08-06
AU682361B2 (en) 1997-10-02
EP0696198B1 (de) 2001-01-17
ES2155472T3 (es) 2001-05-16
WO1994023735A1 (en) 1994-10-27
PT696198E (pt) 2001-07-31
DE69426598D1 (de) 2001-02-22

Similar Documents

Publication Publication Date Title
OA09711A (en) Epithelins: novel cysteine-rich growth modulating proteins.
CA2054699A1 (en) Growth of vascular endothelial cell growth factor and dna encoding same
GR3035722T3 (en) Novel polypeptide having factor xa inhibitory activity
PT86381A (en) Molecular cloning and expression of human il-3
AU1609992A (en) Novel bacteriocin from lactococcus lactis subspecies lactis
PL307258A1 (en) Peptides capable to block calcium canals with agelenopsis aperta
TW327627B (en) Water purification material, process of preparation thereof and water purification unit
EP0460072A4 (en) Human elastase inhibitor
CA2093819A1 (en) Platelet adhesion inhibitor
JPS6456699A (en) Method for obtaining alpha 1-antitrypsin concentrate from human plasma and its utilization as drug
AU1909995A (en) Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
CA2004202A1 (en) Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
Lekan CORONA TREATMENT AS AN ADHESION PROMOTER FOR UV-/EB-CURABLE COATINGS
EP0181524A3 (de) Lymphokin
UA7184C2 (uk) Контактний спосіб зниження артеріального тиску за методикою шпортюк м.і.
Rawczynska-Englert et al. Staphylococcal endocarditis after valve replacement(9 years of experience).
UA29617A (uk) Спосіб одержання протимікробного фітозасобу з інтерфероніндукуючою активністю

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050408